Log In
BCIQ
Print this Print this
 

PRO-571

  Manage Alerts
Collapse Summary General Information
Company Nautilus Neurosciences Inc.
DescriptionRapid-release diclofenac tablet using dynamic buffering technology (DBT)
Molecular Target Cyclooxygenases (COX)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationPain
Indication DetailsTreat acute pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/21/2009

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today